Literature DB >> 212279

3H-Catecholamine binding to alpha-receptors in rat brain: enhancement by reserpine.

D C U'Prichard, S H Snyder.   

Abstract

(+/-)-3H-Epinephrine and (-)-3H-norepinephrine bind to rat cortex membranes in a saturable manner with dissociation constants of 16.7 and 27 nM respectively. The maximum number of 3H-catecholamine binding sites, 10--12 pmoles/g tissue, and the pharmacological characteristics of (+/-)-3H-epinephrine binding, indicate that the catecholamines label the same alpha-noradrenergic receptor in the rat as does 3H-clonidine. At 25 degrees, (+/-)-3H-epinephrine binding associates rapidly to equilibrium, and dissociates in a biphasic manner. The affinities of alpha-agonists at the 3H-catecholamine binding site are 2--4 fold weaker in the rat than in the calf cortex under the same experimental conditions. Ergot alkaloids and phenoxybenzamine have similar affinities in the two tissues, whereas phentolamine and WB-4101 are 8--10 times weaker in the rat. Reserpine (0.25 mg/kg s.c. per day for 3 weeks) causes 25 and 46% increases in the numbers of (+/-)-3H-epinephrine and 3H-WB-4101 alpha-receptor binding sites respectively, and a 51% increase in the number of 3H-dihydroalprenolol beta-receptor sites, in rat forebrain. Reserpine pretreatment does not alter the affinities of either alpha- or beta-receptor 3H-ligands.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 212279     DOI: 10.1016/0014-2999(78)90339-4

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  10 in total

1.  Brain alpha(2)-adrenoceptors in monoamine-depleted rats: increased receptor density, G coupling proteins, receptor turnover and receptor mRNA.

Authors:  C Ribas; A Miralles; X Busquets; J A García-Sevilla
Journal:  Br J Pharmacol       Date:  2001-04       Impact factor: 8.739

2.  Characterization of alpha-adrenergic receptors in guinea pig cerebral cortex: effect of chronic antidepressant treatments.

Authors:  H Y Hu; J M Davis; G N Pandey
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

3.  beta-Adrenoceptor ligand binding and supersensitivity to isoprenaline of ventricular muscle after chronic reserpine pretreatment.

Authors:  M H Hawthorn; K J Broadley
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-09       Impact factor: 3.000

4.  Involvement of catecholamines in Haemophilus influenzae induced decrease of beta-adrenoceptor function.

Authors:  A J Schreurs; D H Versteeg; F P Nijkamp
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-09       Impact factor: 3.000

5.  Up- and down- regulation of central postsynaptic alpha 2 receptors reflected in the growth hormone response to clonidine in reserpine-pretreated rats.

Authors:  E Eriksson; S Edén; K Modigh
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

6.  Temperature-induced changes in dissociation constants (KA) of agonists at cardiac beta-adrenoceptors determined by use of the irreversible antagonist Ro 03-7894.

Authors:  K J Broadley; R G Williams
Journal:  Br J Pharmacol       Date:  1983-06       Impact factor: 8.739

7.  Increased numbers of alpha receptors in sympathetic denervation supersensitivity in man.

Authors:  B Davies; D Sudera; G Sagnella; E Marchesi-Saviotti; C Mathias; R Bannister; P Sever
Journal:  J Clin Invest       Date:  1982-04       Impact factor: 14.808

8.  Agonist binding at alpha 2-adrenoceptors of human platelets using 3H-UK-14,304: regulation by Gpp(NH)p and cations.

Authors:  J Schloos; A Wellstein; D Palm
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-07       Impact factor: 3.000

9.  Evidence for the lack of interaction between (+/-)-1-O-octadecyl-2-acetylglyceryl-3-phosphorylcholine and alpha-adrenoceptors in vivo and in vitro.

Authors:  P Cervoni; B M Goldstein; H Herzlinger; F M Lai; G J Quirk
Journal:  Br J Pharmacol       Date:  1984-10       Impact factor: 8.739

10.  GABAergic effects of reserpine following chronic treatment.

Authors:  P D Suzdak; G Gianutsos
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.